Healthcare - Biotechnology - NASDAQ - US
$ 8.9
-7.77 %
$ 983 M
Market Cap
-3.59
P/E
Price Target
Average
82.58%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.80%
Net Income
Estimate
24.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cogent Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for COGT of $16.2 , with forecasts ranging from a low of $13 to a high of $20 .
COGT Lowest Price Target
Wall Street Target
13 USD
46.07%
COGT Average Price Target
Wall Street Target
16.2 USD
82.58%
COGT Highest Price Target
Wall Street Target
20 USD
124.72%
REVENUE FORECAST
Revenue Forecast Chart COGT
EBIT FORECAST
EBIT Forecast Chart COGT
NET INCOME FORECAST
Net Income Chart COGT